Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.
Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to ...
Learn more about whether Bausch + Lomb Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against the other smid-cap ...
As the name suggests, smid-cap stocks have a valuation between $200 million and $20 billion. The definition is pretty ...
We recently compiled a list of the 10 Hottest Mid-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...
Insights into the digital tools that can help improve patient engagement and advance understanding in deep vein thrombosis ...
Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic ...
Inari shareholders are getting a fair price relative ... risks and costs of thrombolytic therapy (drugs meant to break up clots) and a growing database on the safety and efficacy of mechanical ...
Inari (NASDAQ:NARI) had been working with advisers ... to treat a condition called venous thromboembolism, where a blood clot forms in a vein, and other vascular diseases. Overall, NARI ranks ...